Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02927405Phase 4Withdrawn
Phase 4, randomised, double-blind trial in postoperative pain comparing TAP Block plus placebo with TAP Block plus gabapentin (2 arms). Primary endpoint: Post-operative morphine consumption at 24 hours. Planned start Mar 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02927405.